Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-23

Clinical Trial Update: Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of vancomycin ophthalmic ointment for moderate to severe bacterial conjunctivitis; results have been completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vancomycin ophthalmic ointment (vancomycin)

Snippet

Sponsor: Kurobe LLC | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2024-10-23